PURPOSE: Limited data are available on how symptom burden affects health-related quality of life (HRQoL) in patients with sarcoma. This study aims to describe the symptom burden, HRQoL, and medication use in adult sarcoma patients. METHODS: A single-center, cross-sectional study was conducted, and 79 patients were evaluated using three tools: the Rotterdam Symptom Checklist (RSCL), the Beck Anxiety Inventory (BAI), and the Functional Assessment of Cancer Therapy scale-General (FACT-G). Patients' demographic and clinical information, medication history, and use of concomitant medications were recorded. The proportion of patients with clinically significant RSCL score for a particular symptom was compared with the percentage of patients receiving medication for that symptom. RESULTS: The mean age was 57.3 ± 15.2 years, with majority of the patients diagnosed with stromal tumor (46.8 %), leiomyosarcoma (15.2 %), and liposarcoma (10.1 %). The most prevalent physical symptoms experienced were tiredness (2.38 ± 1.00), lack of energy (2.04 ± 1.02), and difficulty sleeping (2.00 ± 1.15). The most common psychological symptoms experienced were irritability (1.92 ± 1.01), worrying (1.86 ± 0.90), and anxiety (1.68 ± 0.74). Few (6.3 %) patients received hypnotics while 33.0 % of patients reported difficulty sleeping. A proportion of patients (27.9 %) reported experiencing lack of appetite with only 1.3 % received appetite stimulants. CONCLUSION: Adult sarcoma patients experience significant physiological and psychological symptom burden, which has a strong negative impact on HRQoL, with a number of physiological symptoms undertreated with pharmacotherapy.
PURPOSE: Limited data are available on how symptom burden affects health-related quality of life (HRQoL) in patients with sarcoma. This study aims to describe the symptom burden, HRQoL, and medication use in adult sarcomapatients. METHODS: A single-center, cross-sectional study was conducted, and 79 patients were evaluated using three tools: the Rotterdam Symptom Checklist (RSCL), the Beck Anxiety Inventory (BAI), and the Functional Assessment of Cancer Therapy scale-General (FACT-G). Patients' demographic and clinical information, medication history, and use of concomitant medications were recorded. The proportion of patients with clinically significant RSCL score for a particular symptom was compared with the percentage of patients receiving medication for that symptom. RESULTS: The mean age was 57.3 ± 15.2 years, with majority of the patients diagnosed with stromal tumor (46.8 %), leiomyosarcoma (15.2 %), and liposarcoma (10.1 %). The most prevalent physical symptoms experienced were tiredness (2.38 ± 1.00), lack of energy (2.04 ± 1.02), and difficulty sleeping (2.00 ± 1.15). The most common psychological symptoms experienced were irritability (1.92 ± 1.01), worrying (1.86 ± 0.90), and anxiety (1.68 ± 0.74). Few (6.3 %) patients received hypnotics while 33.0 % of patients reported difficulty sleeping. A proportion of patients (27.9 %) reported experiencing lack of appetite with only 1.3 % received appetite stimulants. CONCLUSION: Adult sarcomapatients experience significant physiological and psychological symptom burden, which has a strong negative impact on HRQoL, with a number of physiological symptoms undertreated with pharmacotherapy.
Authors: Saurabh P Nagar; Daniel S Mytelka; Sean D Candrilli; Yulia D'yachkova; Maria Lorenzo; Bernd Kasper; Jose Antonio Lopez-Martin; James A Kaye Journal: Sarcoma Date: 2018-05-24
Authors: Lesley Storey; Lorna A Fern; Ana Martins; Mary Wells; Lindsey Bennister; Craig Gerrand; Maria Onasanya; Jeremy S Whelan; Rachael Windsor; Julie Woodford; Rachel M Taylor Journal: Sarcoma Date: 2019-02-17
Authors: Jonathan R Day; Benjamin Miller; Bradley T Loeffler; Sarah L Mott; Munir Tanas; Melissa Curry; Jonathan Davick; Mohammed Milhem; Varun Monga Journal: Front Psychol Date: 2022-09-29
Authors: Daniel S Mytelka; Saurabh P Nagar; Yulia D'yachkova; Elizabeth M La; James A Kaye; Sean D Candrilli; Bernd Kasper; Jose Antonio Lopez-Martin; Maria Lorenzo Journal: Sarcoma Date: 2018-09-12
Authors: Dide den Hollander; Winette T A Van der Graaf; Marco Fiore; Bernd Kasper; Susanne Singer; Ingrid M E Desar; Olga Husson Journal: ESMO Open Date: 2020-10
Authors: Leopold Hentschel; Stephan Richter; Hans-Georg Kopp; Bernd Kasper; Annegret Kunitz; Viktor Grünwald; Torsten Kessler; Jens Marcus Chemnitz; Uwe Pelzer; Ulrich Schuler; Janet Freitag; Andrea Schilling; Beate Hornemann; Karin Arndt; Martin Bornhäuser; Markus Kajo Schuler Journal: BMJ Open Date: 2020-08-27 Impact factor: 2.692
Authors: Mrinal Gounder; Albiruni R Abdul Razak; Adrienne M Gilligan; Hoyee Leong; Xiwen Ma; Neeta Somaiah; Sant P Chawla; Javier Martin-Broto; Giovanni Grignani; Scott M Schuetze; Bruno Vincenzi; Andrew J Wagner; Bartosz Chmielowski; Robin L Jones; Jatin Shah; Sharon Shacham; Michael Kauffman; Richard F Riedel; Steven Attia Journal: Future Oncol Date: 2021-04-15 Impact factor: 3.674